(VIANEWS) – BE SEMICONDUCTOR (BESI.AS), SANDNES SPAREBANK (SADG.OL), ABN AMRO BANK N.V. (ABN.AS) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio at the moment. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. BE SEMICONDUCTOR (BESI.AS)
131.62% Payout Ratio
BE Semiconductor Industries N.V. engages in the development, manufacture, marketing, sale, and service of semiconductor assembly equipment for the semiconductor and electronics industries worldwide. The company's principal products include die attach equipment, such as single chip, multi-chip, multi module, flip chip, thermal compression bonding, fan out wafer level packaging, hybrid and embedded bridge die bonding, and die sorting systems; and packaging equipment, including conventional, ultra-thin, and wafer level molding, as well as trim and form, and singulation systems. Its principal products also comprise plating equipment, such as tin, copper, and precious metal and solar plating systems, as well as related process chemicals; and tooling, conversion kits, spare parts, and other services. The company's principal brand names include Datacon, Esec, Fico, and Meco. It offers its products primarily to multinational chip manufacturers, assembly subcontractors, and electronics and industrial companies. The company was incorporated in 1995 and is headquartered in Duiven, the Netherlands.
Earnings Per Share
As for profitability, BE SEMICONDUCTOR has a trailing twelve months EPS of €2.53.
PE Ratio
BE SEMICONDUCTOR has a trailing twelve months price to earnings ratio of 33.79. Meaning, the purchaser of the share is investing €33.79 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.18%.
More news about BE SEMICONDUCTOR.
2. SANDNES SPAREBANK (SADG.OL)
66.05% Payout Ratio
Sandnes Sparebank, an independent savings bank, provides a range of banking and investment products to retail and corporate customers in Norway. It operates through three segments: Retail Market, Corporate Market, and Real Estate. The company offers fixed rate deposits, deposit accounts, BSU, and tax withholding and other accounts; child, death, income, critical illness, disability, car, home, cabin, contents, UNG, and other insurance products; and pension solutions. It also provides bank guarantee, overdrafts, leasing, construction and business loans, factoring and invoice sales; fixed interest, mortgage, car, and other vehicle loans, as well as small loans and refinancing, and green loans; bank and credit cards; various loans and guarantees; and mobile and internet banking services. In addition, the company offers real estate brokerage and general investment advisory services. Sandnes Sparebank was founded in 1875 and is headquartered in Sandnes, Norway.
Earnings Per Share
As for profitability, SANDNES SPAREBANK has a trailing twelve months EPS of kr8.1.
PE Ratio
SANDNES SPAREBANK has a trailing twelve months price to earnings ratio of 10.62. Meaning, the purchaser of the share is investing kr10.62 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.23%.
Moving Average
SANDNES SPAREBANK’s worth is below its 50-day moving average of kr91.02 and under its 200-day moving average of kr91.05.
Volume
Today’s last reported volume for SANDNES SPAREBANK is 141 which is 98.65% below its average volume of 10498.
More news about SANDNES SPAREBANK.
3. ABN AMRO BANK N.V. (ABN.AS)
47.45% Payout Ratio
ABN AMRO Bank N.V. provides various banking products and services to retail, private, and business clients in the Netherlands and internationally. It operates through three segments: Personal & Business Banking, Wealth Management, and Corporate Banking. The company provides savings and deposits products; labelled residential mortgage products under the Florius brands; and consumer loans under the Alpha Credit Nederland, Credivance, Defam, Moneyou, and ABN AMRO brands. It also issues, promotes, manages, and processes credit cards; provides revolving credit card facilities and pension schemes, as well as consumer credit and mortgages; and life and non-life insurance products. In addition, it offers asset-based solutions, including working capital solutions, equipment leases and loans, and vendor lease services; private banking and wealth-management-related services; and derivatives and equity clearing services. ABN AMRO Bank N.V. was incorporated in 2009 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, ABN AMRO BANK N.V. has a trailing twelve months EPS of €1.96.
PE Ratio
ABN AMRO BANK N.V. has a trailing twelve months price to earnings ratio of 7.08. Meaning, the purchaser of the share is investing €7.08 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.34%.
Sales Growth
ABN AMRO BANK N.V.’s sales growth for the current quarter is 10.1%.
Yearly Top and Bottom Value
ABN AMRO BANK N.V.’s stock is valued at €13.88 at 17:10 EST, way under its 52-week high of €17.00 and way above its 52-week low of €8.69.
More news about ABN AMRO BANK N.V..
4. DSM KON (DSM.AS)
40% Payout Ratio
Koninklijke DSM N.V., a science-based company, engages in health and nutrition businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Animal Nutrition & Health (ANH); Health, Nutrition & Care (HNC); and Food & Beverage segments. The Animal Nutrition & Health segment offers essential products, including vitamins, premixes, and carotenoids; performance solutions, such as enzymes, microbes, and eubiotics; precision services comprising support with data analysis to measure animal health and environmental footprint on farm level and feed safety; and methane reducing feed additive for ruminants. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, personal care and aroma, and biomedical materials markets. It offers vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, and sunscreen filters, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise, and customized solutions. The Food & Beverage segment provides ingredients and solutions for use in a range of food products, such as dairy; bakery, cereals, and bars; savory foods; beverages and brewing; confectionery and fruit; plant-based meat and fish alternatives; and petfood. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.
Earnings Per Share
As for profitability, DSM KON has a trailing twelve months EPS of €6.26.
PE Ratio
DSM KON has a trailing twelve months price to earnings ratio of 18.27. Meaning, the purchaser of the share is investing €18.27 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.69%.
Sales Growth
DSM KON’s sales growth is 46.8% for the current quarter and 13.9% for the next.
Volume
Today’s last reported volume for DSM KON is 21318 which is 95.35% below its average volume of 458796.
More news about DSM KON.
5. EQUASENS (EQS.PA)
37.7% Payout Ratio
Equasens Société anonyme provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists' business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services. In addition, it offers a ULTIMATE, a system combining optimized pharmacy management and improved patient support; FARMACLICK, a protocol for communications between pharmacies and wholesalers-distributors; DIFARM, a solution for wholesalers-distributors; PHARE, a retail management tool; SOPHIA, a pharmacy management application; OffiMédia POS display; eNephro to enhance the care of chronic renal failure patients; and TPE Pilot, a web-based application that simplifies the management and sharing of patient education programs. Further, the company provides NOVIACARE; CARELIB Domicile; CARELIB EHPAD; KAPELSE solutions; TITAN solutions; ANTHADINE software and MOBISOINS mobile tool; MICROSOINS, an in-home nursing care solution; and LOGICLIC. Additionally, it offers AXIGATE solutions to manage the entire patient care pathway; CHORUS platform; medical telesecretarial services for healthcare professionals; and equipment lease financing solutions. The company was incorporated in 1996 and is based in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
Earnings Per Share
As for profitability, EQUASENS has a trailing twelve months EPS of €3.05.
PE Ratio
EQUASENS has a trailing twelve months price to earnings ratio of 24.56. Meaning, the purchaser of the share is investing €24.56 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.59%.
Sales Growth
EQUASENS’s sales growth for the current quarter is 7%.
Volume
Today’s last reported volume for EQUASENS is 1746 which is 51.52% below its average volume of 3602.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.3%, now sitting on 202.74M for the twelve trailing months.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 30, 2022, the estimated forward annual dividend rate is 1.05 and the estimated forward annual dividend yield is 1.47%.
More news about EQUASENS.
